|
Generalized Anxiety Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
We investigated associations of antibodies against the 65 kDa isoform of GAD (GAD65) with type 1 diabetes and type 2 diabetes genetic risk scores and incident diabetes in adults in European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct, a case-cohort study nested in the EPIC cohort.
|
31713011 |
2020 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
African American and Caucasian participants from three community-based clinical trials testing treatments for late-life worry/anxiety were pooled to examine the factor structure, internal consistency reliability, and convergent, discriminant, and predictive validity of the Penn State Worry Questionnaire-Abbreviated (PSWQ-A), Generalized Anxiety Disorder-7 (GAD-7) and Geriatric Anxiety Inventory-short form (GAI-SF).
|
30810345 |
2020 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This was a cross-sectional study.The Aggression Questionnaire (AQ-K), the Insomnia Severity Index (ISI), the Epworth Sleepiness Scale (ESS), the Patient Health Questionnaire-9 (PHQ-9), and the Generalized Anxiety Disorder-7 (GAD-7) were utilized in the study.
|
31835057 |
2020 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In this prospective observational study, 200 patients admitted to two level 4 EMUs completed standardized surveys including the Quality of Life in Epilepsy (QOLIE-31-P), Generalized Anxiety Disorder 7-item (GAD-7), Patient Health Questionnaire (PHQ-9), and Beck Depression Inventory-II (BDI-II).
|
31759316 |
2020 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
To assess the levels of depression and anxiety, the PHQ-9 (The Patient Health Questionnaire), GAD-7 (Generalized Anxiety Disorder), SHS (Subjective Happiness Scale), and IPIP Big-5 questionnaires were used.
|
31117829 |
2020 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
To address this gap, this study used data from the Intern Health Study, which follows students from the end of medical school through the first year of residency, recording depression via the 9-item Patient Health Questionnaire (PHQ-9), anxiety via the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7), and multiple risk factors for these symptoms.
|
31084447 |
2020 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Patient Health Questionnaires for depression (PHQ-9) and Generalized Anxiety Disorder 7-item (GAD-7) were collected for patients attending an initial consultation (n=79) or follow-up appointment (n=115).
|
30530884 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
<b>Methods</b>: A sample of 409 humanitarian volunteers from the Sudanese Red Crescent Society completed an online, anonymous, survey comprised of the Perceived Supervision, Perceived Organizational Support, Team Support, and Perceived Psychological Stress scales, as well as the Generalized Anxiety Disorder and Patient Health Questionnaire scales, (GAD-7 and PHQ- 8), and the Warwick-Edinburgh Mental Well-being Scale.
|
31839900 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Secondary outcomes were total scores on the Patient Health Questionnaire-9 item (PHQ-9), the Generalized Anxiety Disorder Questionnaire-7 item (GAD-7), the EuroQOL 5-dimension quality of life questionnaire (EQ-5D-5L), and the Community Integration Questionnaire.
|
31165710 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
A questionnaire set, including sociodemographic variables, Patient Health Questionnaire-9 (PHQ-9), and the Generalized Anxiety Disorder Scale-7 (GAD-7), was completed by the participants.
|
30762438 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
We evaluated sensitivity, specificity, accuracy, and risk for progression to T1D associated with oxPTM-INS-Ab and the standard islet AAB that include insulin (IAA), GAD (GADA), and tyrosine phosphatase 2 (IA-2A) in a cohort of islet AAB-positive (AAB<sup>+</sup> ) children from the general population (median follow-up 8.8 years).
|
30693639 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
The titer of anti-GAD in our patient (30 U/ml) was consistent with a variant called "low-titer anti-GAD syndrome".
|
30136028 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The 7-item Generalized Anxiety Disorder Scale (GAD-7) and the 9-item Patient Health Questionnaire (PHQ-9) were used to assess the anxiety and depressive symptoms of the mothers of the autistic children.
|
31393408 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Participants showed significant reductions in the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) across all treatment arms (P s<.001).
|
31464192 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
A score of 10 or greater for GAD-7 (of total 21) indicates a probable generalized anxiety disorder.
|
30611061 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Data were collected during a two-month period using the Lavender Satisfaction Assessment and the Generalized Anxiety Disorder-7 (GAD-7) scale.
|
31538981 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In this cross-sectional study, a total of 539 patients with infertility from a referral infertility clinic in Tehran, Iran completed the PHQ-9, along with other relevant scales: the WHO-five Well-being Index (WHO-5), the Hospital Anxiety and Depression Scale (HADS), and the Generalized Anxiety Disorder-7 (GAD-7).
|
31500644 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Participants with brain tumour completed the Brief Test of Adult Cognition by Telephone, Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), ratings of physical symptoms, Depression Scale of the Depression Anxiety Stress Scales-21 (DASS-Depression), and Generalized Anxiety Disorder-7 (GAD-7) scale.
|
31313128 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Participants were applied SCID I and II and filled CAS-1 scale, Meta-Cognitions Questionnaire-30 (MCQ-30), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Generalized Anxiety Disorder-7 (GAD-7) Scale, and Penn State Worry Questionnaire (PSWQ).
|
31132839 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Somatic and cognitive symptom scores derived from Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder Scale (GAD-7) were used to assess mood symptoms.
|
30836983 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A prospective study.Patients with and without voice conditions were administered with the VCI, Voice-Related Quality of Life (V-RQOL), and the Generalized Anxiety Disorder-7 (GAD-7)questionnaires.
|
29132807 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
YYFcore03, Patient Health Questionnaire [PHQ-9], and Generalized Anxiety Disorder [GAD-7] were administered to 608 patients in out-patient clinics.
|
31659816 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patients referred to a urogynecology clinic for LUTS completed two questionnaires: the International Consultation on Incontinence Modular Questionnaire for Overactive Bladder (ICIQ-OAB), and the Generalized Anxiety Disorder 7-Item Scale (GAD-7).
|
31302716 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Psychological and sexual well-being was assessed with Beck Depression Inventory (BDI21), Generalized Anxiety Disorder 7 (GAD-7) and female sexual function Index (FSFI) questionnaires.
|
31505457 |
2019 |
|
Generalized Anxiety Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Participation was via an anonymous REDCap survey, which consisted of sociodemographic questions followed by the brief pain inventory-short form (BPI-SF), patient health questionnaire-8 (PHQ-8), and generalized anxiety disorder-7 (GAD-7) questionnaires.
|
30637564 |
2019 |